Category: Ankylosing Spondylitis

Study finds combination therapy does little to slow spine damage in radiographic axial spondyloarthritis patients

New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, showed that combining a…

By Staff , in Ankylosing Spondylitis , at November 8, 2022

There is an unacceptable delay to diagnosis in axial spondyloarthritis

The Axial Spondyloarthritis International Federation (ASIF) set out to coordinate a comprehensive evidence-based global review of the factors influencing the…

By Staff , in Ankylosing Spondylitis , at June 18, 2021

Ankylosing spondylitis (AS): Becoming a mother despite having a rheumatic disease?

Ankylosing spondylitis (AS) is a complex chronic inflammatory disease of the spine with involvement of the sacroiliac joints. Over the…

By Staff , in Ankylosing Spondylitis , at March 17, 2020

Combining NSAIDs and TNFi may reduce radiographic progression in ankylosing spondylitis

The results of a cohort study presented at the Annual European Congress of Rheumatology (EULAR 2018) showed that, in patients…

By Staff , in Ankylosing Spondylitis , at June 17, 2018

Significant increase in self-harm attempts following ankylosing spondylitis diagnosis

The results of a population study presented today at the Annual European Congress of Rheumatology (EULAR 2018) demonstrate a significantly…

By Staff , in Ankylosing Spondylitis , at June 17, 2018

Immune therapy generates promising results in hard-to-treat ankylosing spondylitis

Results from a phase 3 clinical trial indicate that patients who have not benefited from standard therapy for ankylosing spondylitis…

By Staff , in Ankylosing Spondylitis , at March 17, 2018